US Stock MarketDetailed Quotes
PCRX Pacira BioSciences
- 18.980
- -0.590-3.01%
Close Dec 20 16:00 ET
- 18.980
- 0.0000.00%
Post 16:15 ET
876.37MMarket Cap-9.59P/E (TTM)
19.800High18.730Low3.17MVolume19.070Open19.570Pre Close60.42MTurnover6.94%Turnover Ratio21.33P/E (Static)46.17MShares35.95052wk High1.17P/B866.90MFloat Cap11.16452wk Low--Dividend TTM45.67MShs Float121.950Historical High--Div YieldTTM5.47%Amplitude6.160Historical Low19.059Avg Price1Lot Size
Pacira BioSciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.83%168.57M | 5.05%178.02M | 4.23%167.12M | 1.22%674.98M | 5.40%181.24M | -2.11%163.93M | 0.03%169.47M | 1.49%160.34M | 23.14%666.82M | 8.02%171.96M |
| Operating revenue | 2.83%168.57M | 5.05%178.02M | 4.23%167.12M | 1.22%674.98M | 5.40%181.24M | -2.11%163.93M | 0.03%169.47M | 1.49%160.34M | 23.14%666.82M | 8.02%171.96M |
| Cost of revenue | -2.23%38.86M | -8.18%44.26M | -3.27%47.42M | -7.34%184.67M | -22.97%47.69M | -21.56%39.75M | -4.78%48.21M | 35.89%49.02M | 42.09%199.3M | 58.73%61.92M |
| Gross profit | 4.46%129.71M | 10.31%133.76M | 7.53%119.7M | 4.87%490.31M | 21.37%133.55M | 6.33%124.18M | 2.08%121.26M | -8.69%111.32M | 16.51%467.53M | -8.44%110.04M |
| Operating expense | 4.52%107.76M | 4.89%102.79M | 2.23%104.59M | 1.61%402.99M | 3.96%99.59M | 8.51%103.1M | -7.21%98M | 2.11%102.31M | 47.74%396.6M | 27.18%95.8M |
| Selling and administrative expenses | 9.40%74.33M | 5.05%68.13M | 1.67%72.03M | 5.86%269.44M | 2.86%65.8M | 10.87%67.95M | -0.24%64.85M | 10.24%70.84M | 27.68%254.52M | 22.66%63.97M |
| -Selling and marketing expense | 12.89%43.19M | 4.23%39.05M | -5.16%39.44M | 5.55%153.04M | -0.72%35.74M | 13.51%38.26M | 1.65%37.46M | 8.17%41.58M | --145M | --36M |
| -General and administrative expense | 4.90%31.14M | 6.17%29.08M | 11.37%32.59M | 6.28%116.4M | 7.47%30.06M | 7.65%29.69M | -2.70%27.39M | 13.34%29.26M | --109.52M | --27.97M |
| Research and development costs | -8.29%19.1M | 8.04%20.34M | 6.41%18.24M | -10.07%76.26M | 11.19%19.46M | 7.34%20.83M | -28.38%18.82M | -20.67%17.14M | 52.66%84.8M | 12.83%17.51M |
| Depreciation amortization depletion | 0.00%14.32M | 0.00%14.32M | 0.00%14.32M | 0.00%57.29M | 0.00%14.32M | 0.00%14.32M | 0.00%14.32M | 0.00%14.32M | 322.70%57.29M | 87.14%14.32M |
| -Depreciation and amortization | 0.00%14.32M | 0.00%14.32M | 0.00%14.32M | 0.00%57.29M | 0.00%14.32M | 0.00%14.32M | 0.00%14.32M | 0.00%14.32M | 322.70%57.29M | 87.14%14.32M |
| Operating profit | 4.14%21.95M | 33.15%30.98M | 67.65%15.12M | 23.12%87.32M | 138.49%33.97M | -3.22%21.08M | 76.55%23.26M | -58.51%9.02M | -46.61%70.93M | -68.26%14.24M |
| Net non-operating interest income expense | 213.61%793K | 149.32%865K | 109.11%587K | 74.99%-8.86M | 100.45%37K | 91.90%-698K | 79.56%-1.75M | 35.37%-6.45M | -14.84%-35.43M | 20.18%-8.26M |
| Non-operating interest income | 98.19%5.48M | 124.96%4.75M | 24.22%3.9M | 151.96%11.44M | 22.98%3.43M | 124.15%2.77M | 737.70%2.11M | 1,059.41%3.14M | 406.92%4.54M | 3,381.25%2.79M |
| Non-operating interest expense | 38.40%3.85M | -1.67%3.12M | -69.54%2.64M | -51.34%17.31M | -71.83%2.7M | -68.94%2.78M | -60.12%3.17M | -4.58%8.65M | 22.69%35.58M | -0.50%9.6M |
| Total other finance cost | 22.99%840K | 10.42%763K | -27.32%681K | -31.91%3M | -52.56%685K | -24.36%683K | -20.94%691K | -20.53%937K | 59.77%4.4M | 85.60%1.44M |
| Other net income (expense) | -4,177.37%-161.6M | -70.97%4.74M | 92.90%-2.06M | 24.47%-16.76M | 98.82%-283K | 65.92%-3.78M | -6.13%16.34M | -551.04%-29.04M | 51.31%-22.19M | 40.93%-24.05M |
| Special income (charges) | -4,711.59%-161.48M | -71.21%4.78M | 93.45%-1.9M | -52.01%-16.57M | 96.69%-798K | -586.30%-3.36M | -8.00%16.61M | -569.43%-29.03M | 74.59%-10.9M | 40.63%-24.14M |
| -Less：Restructuring and merger&acquisition | -152.62%-1.77M | 116.46%2.74M | -84.28%1.9M | -103.23%-352K | -96.69%798K | 586.30%3.36M | 8.00%-16.61M | 179.16%12.11M | -74.59%10.9M | -40.63%24.14M |
| -Less:Impairment of capital assets | --163.24M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Less:Other special charges | ---- | ---7.52M | ---- | --16.93M | --0 | ---- | ---- | --16.93M | ---- | ---- |
| Other non- operating income (expenses) | 71.09%-122K | 85.50%-39K | -1,490.00%-159K | 98.35%-186K | 535.80%515K | 96.02%-422K | 58.42%-269K | 91.94%-10K | -323.41%-11.29M | 222.73%81K |
| Income before tax | -936.43%-138.86M | -3.35%36.58M | 151.52%13.64M | 363.85%61.7M | 286.63%33.72M | 702.37%16.6M | 72.01%37.85M | -462.96%-26.47M | -76.42%13.3M | -191.51%-18.07M |
| Income tax | -19.73%4.61M | 46.37%17.7M | 167.18%4.66M | 857.42%19.75M | 211.10%8.85M | 107.93%5.74M | 467.39%12.09M | -1,588.84%-6.94M | -118.07%-2.61M | -645.88%-7.97M |
| Net income | -1,421.29%-143.47M | -26.69%18.89M | 145.96%8.98M | 163.72%41.96M | 346.19%24.87M | 1,666.81%10.86M | 29.62%25.76M | -386.12%-19.54M | -62.10%15.91M | -96.92%-10.1M |
| Net income continuous Operations | -1,421.29%-143.47M | -26.69%18.89M | 145.96%8.98M | 163.72%41.96M | 346.19%24.87M | 1,666.81%10.86M | 29.62%25.76M | -386.12%-19.54M | -62.10%15.91M | -96.92%-10.1M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -1,421.29%-143.47M | -26.69%18.89M | 145.96%8.98M | 163.72%41.96M | 346.19%24.87M | 1,666.81%10.86M | 29.62%25.76M | -386.12%-19.54M | -62.10%15.91M | -96.92%-10.1M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -1,421.29%-143.47M | -26.69%18.89M | 145.96%8.98M | 163.72%41.96M | 346.19%24.87M | 1,666.81%10.86M | 29.62%25.76M | -386.12%-19.54M | -62.10%15.91M | -96.92%-10.1M |
| Basic earnings per share | -1,452.17%-3.11 | -26.79%0.41 | 144.19%0.19 | 160.00%0.91 | 345.45%0.54 | 1,250.00%0.23 | 27.27%0.56 | -386.67%-0.43 | -63.16%0.35 | -83.33%-0.22 |
| Diluted earnings per share | -1,452.17%-3.11 | -23.53%0.39 | 144.19%0.19 | 161.76%0.89 | 336.36%0.52 | 1,250.00%0.23 | 27.50%0.51 | -386.67%-0.43 | -63.04%0.34 | -83.33%-0.22 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data